Elevance Health ELV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $200.42B+9.3% | $199.13B+12.5% | $194.82B+11.8% | $189.22B+10.0% | $183.33B+6.7% | ||
| $21.66B+3.6% | $21.18B+7.2% | $21.67B+16.7% | $21.38B+17.9% | $20.91B+18.5% | ||
| $178.76B+10.1% | $177.95B+13.2% | $173.15B+11.3% | $167.83B+9.1% | $162.42B+5.4% | ||
| 89.2%+0.6pp | 89.4%+0.5pp | 88.9%-0.5pp | 88.7%-0.8pp | 88.6%-1.1pp | ||
| $22.01B+7.7% | $20.98B+4.8% | $20.37B+0.8% | $20.37B-0.2% | $20.44B+1.3% | ||
| $1.42B+11.9% | $1.4B+18.3% | $1.38B+24.6% | $1.33B+24.6% | $1.26B+21.1% | ||
| $6.22B-19.9% | $6.71B-15.1% | $7.1B-14.4% | $7.07B-17.6% | $7.76B-3.4% | ||
| —— | —— | $1.57B-17.6% | $1.72B-9.5% | $1.86B+3.2% | ||
| $5.24B-11.4% | $5.66B-5.3% | $5.53B-13.8% | $5.36B-19.9% | $5.92B-5.2% | ||
| 2.6%-0.6pp | 2.8%-0.5pp | 2.8%-0.8pp | 2.8%-1.1pp | 3.2%-0.4pp | ||
| $23.58-8.2% | $25.19-1.9% | $24.52-10.7% | $23.56-17.5% | $25.69-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elevance Health's revenue?
- Elevance Health (ELV) generated $200.42B in revenue over the trailing twelve months, up 9.3% year over year.
- Is Elevance Health profitable?
- Elevance Health reported $5.2B in net income over the trailing twelve months, a 2.6% net margin.
- What is Elevance Health's earnings per share?
- Elevance Health's diluted EPS over the trailing twelve months is $23.58.
- Where does Elevance Health's income statement data come from?
- Every line is extracted from Elevance Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
